Biological activity of recombinant human growth factors released from biocompatible bone implants

Journal of Biomedical Materials Research - Part A

Volumn 86, Issue 1, 2008, Pages 89-97

  Ziegler, Joerg ^a   Anger, Dominique ^a   Krummenauer, Frank ^a   Breitig, Dieter ^b   Fickert, Stefan ^a   Guenther, Klaus Peter ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Biological activity; Bone implant; Growth factor

Indexed keywords

ANIMAL CELL CULTURE; BIOACTIVITY; BIOMATERIALS; BONE; CELL GROWTH; CELL PROLIFERATION; COATING TECHNIQUES; GLASS CERAMICS; HYDROXYAPATITE; PEPTIDES; PROTEINS; RHODIUM; TISSUE;

(1 1 0) SURFACE; ALKALINE PHOSPHATASE (ALPASE); ALPHA TRICALCIUM PHOSPHATE; BASIC FIBROBLAST GROWTH FACTOR (BFGF); BIOLOGICAL ACTIVITIES; BONE IMPLANTS; CELL COUNTERS; CELL DIFFERENTIATION; CELL NUMBERS; CONCENTRATION (COMPOSITION); CULTURES (TRADITIONAL); GROWTH FACTORS; IN-VITRO; MTT ASSAYING; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (RHBMP-2); SYNTHETIC IMPLANTS;

CELL CULTURE;

ALKALINE PHOSPHATASE; BIOMATERIAL; CALCIUM PHOSPHATE; GLASS; HYDROXYAPATITE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BIOLOGICAL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CERAMICS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMPLANT; IN VITRO STUDY; OSSIFICATION; OSTEOBLAST;

ALKALINE PHOSPHATASE; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; PROSTHESES AND IMPLANTS; RECOMBINANT PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 44849121600     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31625     Document Type: Article

References (49)

1. Hench LL. Bioactive materials: The potential for tissue regeneration. J Biomed Mater Res 1998;41:511-518.
2. Kessler S, Mayr-Wohlfart U, Ignatius A, Puhl W, Claes L, Gunther KP. Solvent dehydrated bone transplants to bridge segmental bone defects: Histomorphological and biomechanical investigations in an animal model. Arch Orthop Trauma Surg 2001;121:472-475.
3. Kessler S, Mayr-Wohlfart U, Ignatius A, Puhl W, Claes L, Gunther KP. Histomorphological, histomorphometrical and biomechanical analysis of ceramic bone substitutes in a weight-bearing animal model. J Mater Sci Mater Med 2002;13:191-195.
4. Koepp HE, Schorlemmer S, Kessler S, Brenner RE, Claes L, Gunther KP, Ignatius AA. Biocompatibility and osseointegration of beta-TCP: Histomorphological and biomechanical studies in a weight-bearing sheep model. J Biomed Mater Res 2004;70B:209-217.
5. Laffargue P, Hildebrand HF, Rtaimate M, Frayssinet P, Amoureux JP, Marchandise X. Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects. Bone 1999;25(2 Suppl):55S-58S.
6. Ohura K, Hamanishi C, Tanaka S, Matsuda N. Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rhBMP-2. J Biomed Mater Res 1999;44:168-175.
7. Jansen JA, Vehof JW, Ruhe PQ, Kroeze-Deutman H, Kuboki Y, Takita H, Hedberg EL, Mikos AG. Growth factor-loaded scaffolds for bone engineering. J Control Release 2005;101:127-136.
8. Kessler S, Koepp HE, Mayr-Wohlfart U, Ignatius A, Claes L, Puhl W, Gunther KP. Bone morphogenetic protein 2 accelerates osteointegration and remodelling of solvent-dehydrated bone substitutes. Arch Orthop Trauma Surg 2004;124:410-414.
9. Yuan H, Zou P, Yang Z, Zhang X, De Bruijn JD, De Groot K. Bone morphogenetic protein and ceramic-induced osteogenesis. J Mater Sci Mater Med 1998;9:717-721.
10. Baylink DJ, Finkelman RD, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res 1993;8(Suppl 2):S565-S572.
11. Khan SN, Bostrom MP, Lane JM. Bone growth factors. Orthop Clin North Am 2000;31:375-388.
12. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 1998(346):26-37.
13. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-241.
14. Ebara S, Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 2002;27(16 Suppl 1):S10-S15.
15. ten Dijke P, Fu J, Schaap P, Roelen BA. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 2003;85-A (Suppl 3):34-38.
16. Marie PJ, Debiais F, Hay E. Regulation of human cranial osteoblast phenotype by FGF-2. FGFR-2 and BMP-2 signaling. Histol Histopathol. 2002;17:877-885.
17. Marie PJ. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003;316:23-32.
18. Mayr-Wohlfart U, Kessler S, Knochel W, Puhl W, Gunther KP. BMP-4 of Xenopus laevis stimulates differentiation of human primary osteoblast-like cells. J Bone Joint Surg Br 2001;83:144-147.
19. Ziegler J, Mayr-Wohlfart U, Kessler S, Breitig D, Gunther KP. Adsorption and release properties of growth factors from biodegradable implants. J Biomed Mater Res 2002;59:422-428.
20. Briem D, Linhart W, Lehmann W, Meenen NM, Rueger JM. Long-term outcomes after using porous hydroxyapatite ceramics (Endobon) for surgical management of fractures of the head of the tibia. Unfallchirurg 2002;105:128-133.
21. Ignatius AA, Schmidt C, Kaspar D, Claes LE. In vitro biocompatibility of resorbable experimental glass ceramics for bone substitutes. J Biomed Mater Res 2001;55:285-294.
22. Mayr-Wohlfart U, Fiedler J, Gunther KP, Puhl W, Kessler S. Proliferation and differentiation rates of a human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials. J Biomed Mater Res 2001;57:132-139.
23. Greenwood R, Hunter W. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochemistry 1963;89:114-123.
24. Farley JR, Hall SL, Herring S, Tarbaux NM, Matsuyama T, Wergedal JE. Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS-2. Metabolism 1991;40:664-671.
25. Trieb K, Blahovec H. Suramin suppresses growth, alkaline-phosphatase and telomerase activity of human osteosarcoma cells in vitro. Int J Biochem Cell Biol 2003;35:1066-1070.
26. Katthree R, Katthree D, Cary NC. Applied Multivariate Statistics with SAS Software, 2nd ed. SAS Institute Inc; 1999.
27. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 1991;2:187-208.
28. Khan SN, Tomin E, Lane JM. Clinical applications of bone graft substitutes. Orthop Clin North Am 2000;31:389-398.
29. Ludwig SC, Kowalski JM, Boden SD. Osteoinductive bone graft substitutes. Eur Spine J 2000;9(Suppl 1):S119-S125.
30. Seeherman HJ, Azari K, Bidic S, Rogers L, Li XJ, Hollinger JO, Wozney JM. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am 2006;88:1553-1565.
31. Seeherman H, Li R, Bouxsein M, Kim H, Li XJ, Smith-Adaline EA, Aiolova M, Wozney JM. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am 2006;88:144-160.
32. Kroese-Deutman HC, Ruhe PQ, Spauwen PH, Jansen JA. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 2005;26:1131-1138.
33. Meikle MC, Papaioannou S, Ratledge TJ, Speight PM, Watt-Smith SR, Hill PA, Reynolds JJ. Effect of poly DL-lactide-co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. Biomaterials 1994;15:513-521.
34. Lind M, Overgaard S, Soballe K, Nguyen T, Ongpipattanakul B, Bunger C. Transforming growth factor-beta 1 enhances bone healing to unloaded tricalcium phosphate coated implants: An experimental study in dogs. J Orthop Res 1996;14:343-350.
35. Ripamonti U, Bosch C, van den Heever B, Duneas N, Melsen B, Ebner R. Limited chondro-osteogenesis by recombinant human transforming growth factor-beta 1 in calvarial defects of adult baboons (Papio ursinus). J Bone Miner Res 1996;11:938-945.
36. Zellin G, Beck S, Hardwick R, Linde A. Opposite effects of recombinant human transforming growth factor-beta 1 on bone regeneration in vivo: Effects of exclusion of periosteal cells by microporous membrane. Bone 1998;22:613-620.
37. Kessler S, Mayr-Wohlfart U, Ignatius A, Puhl W, Claes L, Gunther KP. The impact of bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) on osseointegration, degradation and biomechanical properties of a synthetic bone substitute. Z Orthop Ihre Grenzgeb 2003;141:472-480.
38. Kim CS, Kim JI, Kim J, Choi SH, Chai JK, Kim CK, Cho KS. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005;26:2501-2507.
39. Midy V, Rey C, Bres E, Dard M. Basic fibroblast growth factor adsorption and release properties of calcium phosphate. J Biomed Mater Res 1998;41:405-411.
40. Sharpe JR, Sammons RL, Marquis PM. Effect of pH on protein adsorption to hydroxyapatite and tricalcium phosphate ceramics. Biomaterials 1997;18:471-476.
41. Laffargue P, Fialdes P, Frayssinet P, Rtaimate M, Hildebrand HF, Marchandise X. Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant. J Biomed Mater Res 2000;49:415-421.
42. Combes C, Rey C. Adsorption of proteins and calcium phosphate materials bioactivity. Biomaterials 2002;23:2817-2823.
43. Radin S, Ducheyne P, Berthold P, Decker S. Effect of serum proteins and osteoblasts on the surface transformation of a calcium phosphate coating: A physicochemical and ultrastructural study. J Biomed Mater Res 1998;39:234-243.
44. Ruhe PQ, Boerman OC, Russel FG, Mikos AG, Spauwen PH, Jansen JA. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 2006;17:919-927.
45. Louis-Ugbo J, Kim HS, Boden SD, Mayr MT, Li RC, Seeher-man H, D'Augusta D, Blake C, Jiao A, Peckham S. Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model. J Orthop Res 2002;20:1050-1059.
46. Kaito T, Myoui A, Takaoka K, Saito N, Nishikawa M, Tamai N, Ohgushi H, Yoshikawa H. Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials 2005;26:73-79.
47. Park YJ, Kim KH, Lee JY, Ku Y, Lee SJ, Min BM, Chung CP. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol Appl Biochem 2006;43(Pt 1):17-24.
48. Keskin DS, Tezcaner A, Korkusuz P, Korkusuz F, Hasirci V. Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair. Biomaterials 2005;26:4023-4034.
49. Winkler L, Bingmann D, Wiemann M. Heat treatment of BMP-2 depots on implant materials generates an immobilized layer of BMP-2 with pronounced bioactivity. J Biomed Mater Res A 2006;79:895-901.